• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRAIL(肿瘤坏死因子相关凋亡诱导配体)通过半胱天冬酶介导的 PPARγ 切割来调节脂肪细胞代谢。

TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.

机构信息

Division of Pediatric Endocrinology, Diabetes and Obesity Unit, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

出版信息

Cell Death Dis. 2013 Jan 24;4(1):e474. doi: 10.1038/cddis.2012.212.

DOI:10.1038/cddis.2012.212
PMID:23348588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3563999/
Abstract

Tumor necrosis factor α (TNFα) and other members of the TNF family affect adipose tissue metabolism and contribute to the obesity-related inflammation of adipose tissue. Here, we sought to identify the effects of TRAIL (TNF-related apoptosis-inducing ligand) on fat cell biology. TRAIL-receptor 2 (TRAIL-R2) and its mouse homolog DR5 were regulated upon acute and chronic energy imbalance in murine and human adipose tissue. TRAIL inhibited insulin-stimulated glucose uptake and de novo lipogenesis in human adipocytes. Interestingly, TRAIL did not interfere with the phosphorylation of insulin-stimulated kinases such as Akt or Erk and did not activate the NF-κB pathway. Instead, TRAIL activated cleavage of caspase-8 and caspase-3. The subsequent cleavage of PPARγ led to its inactivation and resulted in reduced expression of lipogenic genes, such as Glut-4, FASN, and ACC. Taken together, we discovered a so far unknown function of the death ligand TRAIL in regulating adipocyte metabolism. Our results imply that TRAIL/TRAIL-R system might provide a new target for the prevention and treatment of obesity and its co-morbidities.

摘要

肿瘤坏死因子 α(TNFα)和 TNF 家族的其他成员影响脂肪组织代谢,并导致与肥胖相关的脂肪组织炎症。在这里,我们试图确定 TRAIL(TNF 相关凋亡诱导配体)对脂肪细胞生物学的影响。TRAIL 受体 2(TRAIL-R2)及其小鼠同源物 DR5 在小鼠和人类脂肪组织的急性和慢性能量失衡中受到调节。TRAIL 抑制人脂肪细胞中胰岛素刺激的葡萄糖摄取和从头脂肪生成。有趣的是,TRAIL 不干扰胰岛素刺激的激酶如 Akt 或 Erk 的磷酸化,也不激活 NF-κB 途径。相反,TRAIL 激活了 caspase-8 和 caspase-3 的裂解。随后的 PPARγ 裂解导致其失活,并导致脂肪生成基因如 Glut-4、FASN 和 ACC 的表达减少。总之,我们发现了死亡配体 TRAIL 在调节脂肪细胞代谢中的一个迄今未知的功能。我们的结果表明,TRAIL/TRAIL-R 系统可能为肥胖及其合并症的预防和治疗提供新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/563ca333293d/cddis2012212f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/974c728358f4/cddis2012212f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/feb266f862f6/cddis2012212f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/235cda4f2f86/cddis2012212f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/7587d0fc356c/cddis2012212f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/a5a685c629fa/cddis2012212f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/63e658c86d53/cddis2012212f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/563ca333293d/cddis2012212f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/974c728358f4/cddis2012212f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/feb266f862f6/cddis2012212f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/235cda4f2f86/cddis2012212f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/7587d0fc356c/cddis2012212f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/a5a685c629fa/cddis2012212f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/63e658c86d53/cddis2012212f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/3563999/563ca333293d/cddis2012212f7.jpg

相似文献

1
TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.TRAIL(肿瘤坏死因子相关凋亡诱导配体)通过半胱天冬酶介导的 PPARγ 切割来调节脂肪细胞代谢。
Cell Death Dis. 2013 Jan 24;4(1):e474. doi: 10.1038/cddis.2012.212.
2
TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors.肿瘤坏死因子相关凋亡诱导配体(TRAIL)通过半胱天冬酶介导的脂肪生成转录因子下调来抑制人脂肪细胞分化。
Cell Death Dis. 2016 Oct 13;7(10):e2412. doi: 10.1038/cddis.2016.286.
3
Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.DR5在死亡和生存信号传导中的双重作用导致癌细胞对TRAIL产生抗性。
Cell Death Dis. 2017 Aug 31;8(8):e3025. doi: 10.1038/cddis.2017.423.
4
TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.肿瘤坏死因子相关凋亡诱导配体通过激活细胞外信号调节激酶1/2促进人前脂肪细胞增殖。
FASEB J. 2015 Jul;29(7):3065-75. doi: 10.1096/fj.14-267278. Epub 2015 Apr 9.
5
DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.DR5 介导的 DISC 控制人胶质母细胞瘤中 caspase-8 的切割和凋亡的起始。
J Cell Mol Med. 2010 Jun;14(6A):1303-17. doi: 10.1111/j.1582-4934.2009.00777.x. Epub 2009 May 11.
6
Dexamethasone induces pancreatic β-cell apoptosis through upregulation of TRAIL death receptor.地塞米松通过上调 TRAIL 死亡受体诱导胰岛β细胞凋亡。
J Mol Endocrinol. 2021 Aug 5;67(3):95-106. doi: 10.1530/JME-20-0238.
7
DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.DR4特异性TRAIL变体在胰腺癌中比野生型TRAIL更有效。
Cancer Biol Ther. 2014;15(12):1658-66. doi: 10.4161/15384047.2014.972183.
8
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.以天然产物靶向肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体作为癌症治疗的一种潜在治疗方法。
Exp Biol Med (Maywood). 2015 Jun;240(6):760-73. doi: 10.1177/1535370215579167. Epub 2015 Apr 7.
9
High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.4,5-二甲氧基-2-硝基苯甲醛增加人前列腺癌和结肠癌转移细胞对 TRAIL 的敏感性,并使 TRAIL 不敏感的原代细胞对 TRAIL 敏感。
Mol Cancer. 2011 Apr 25;10:46. doi: 10.1186/1476-4598-10-46.
10
TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.在缺乏半胱天冬酶-8的情况下,TRAIL诱导的小细胞肺癌(SCLC)细胞存活和增殖由细胞外信号调节激酶(ERK)介导,并依赖于TRAIL-R2/死亡受体5(DR5)的表达。
Lung Cancer. 2008 Jun;60(3):355-65. doi: 10.1016/j.lungcan.2007.11.005. Epub 2008 Feb 21.

引用本文的文献

1
Defective Olfactomedin-2 connects adipocyte dysfunction to obesity.嗅觉介蛋白-2缺陷将脂肪细胞功能障碍与肥胖联系起来。
Nat Commun. 2025 Aug 4;16(1):7154. doi: 10.1038/s41467-025-62430-5.
2
Cell death and cancer: Metabolic interconnections.细胞死亡与癌症:代谢关联
Cell Rep. 2025 Jun 24;44(6):115804. doi: 10.1016/j.celrep.2025.115804. Epub 2025 Jun 7.
3
G protein coupled receptor in apoptosis and apoptotic cell clearance.G蛋白偶联受体在细胞凋亡及凋亡细胞清除中的作用

本文引用的文献

1
The energy balance positively regulates the levels of circulating TNF-related apoptosis inducing ligand in humans.能量平衡可正向调节人体中循环肿瘤坏死因子相关凋亡诱导配体的水平。
Clin Nutr. 2012 Dec;31(6):1018-21. doi: 10.1016/j.clnu.2012.04.016. Epub 2012 May 24.
2
Downregulation of FLIP by cycloheximide sensitizes human fat cells to CD95-induced apoptosis.环己酰亚胺下调 FLIP 表达可增强人脂肪细胞对 CD95 诱导凋亡的敏感性。
Exp Cell Res. 2011 Sep 10;317(15):2200-9. doi: 10.1016/j.yexcr.2011.06.016. Epub 2011 Jul 2.
3
TNFR1-induced activation of the classical NF-κB pathway.
FASEB Bioadv. 2024 Aug 6;6(9):289-297. doi: 10.1096/fba.2024-00067. eCollection 2024 Sep.
4
Inflammo-immune perspective on the association of eight migraine risk factors with migraine: a multi-omics Mendelian randomization study.炎症免疫视角下八种偏头痛风险因素与偏头痛的关联:一项多组学孟德尔随机化研究
Front Neurol. 2024 Aug 7;15:1440995. doi: 10.3389/fneur.2024.1440995. eCollection 2024.
5
Genetic Investigation of the Trail Mechanism in Diabetic and Non-diabetic Obese Patients.糖尿病和非糖尿病肥胖患者中TRAIL机制的遗传学研究。
Biochem Genet. 2024 Oct;62(5):3893-3903. doi: 10.1007/s10528-023-10624-1. Epub 2024 Jan 19.
6
20 Years with SGBS cells - a versatile in vitro model of human adipocyte biology.20 年的 SGBS 细胞研究——人类脂肪细胞生物学的多功能体外模型。
Int J Obes (Lond). 2022 Nov;46(11):1939-1947. doi: 10.1038/s41366-022-01199-9. Epub 2022 Aug 19.
7
Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence.重新定位肿瘤坏死因子相关凋亡诱导配体 (TRAIL) 在 TRAIL 致糖尿病发病机制中的作用:实验与临床证据的更新。
Int J Mol Sci. 2022 Mar 17;23(6):3225. doi: 10.3390/ijms23063225.
8
TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake.TRAIL/DR5 通路促进 AKT 磷酸化、骨骼肌分化和葡萄糖摄取。
Cell Death Dis. 2021 Nov 16;12(12):1089. doi: 10.1038/s41419-021-04383-3.
9
Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients.全面分析炎症因子表明,生长分化因子 15 是 COVID-19 患者疾病严重程度的指标。
Front Immunol. 2021 Jul 15;12:662465. doi: 10.3389/fimmu.2021.662465. eCollection 2021.
10
A TRAIL-TL1A Paracrine Network Involving Adipocytes, Macrophages, and Lymphocytes Induces Adipose Tissue Dysfunction Downstream of E2F1 in Human Obesity.肥胖症患者脂肪细胞、巨噬细胞和淋巴细胞中的 TRAIL-TL1A 旁分泌网络通过 E2F1 诱导下游脂肪组织功能障碍。
Diabetes. 2020 Nov;69(11):2310-2323. doi: 10.2337/db19-1231. Epub 2020 Jul 30.
肿瘤坏死因子受体 1 诱导的经典 NF-κB 通路的激活。
FEBS J. 2011 Apr;278(6):862-76. doi: 10.1111/j.1742-4658.2011.08015.x. Epub 2011 Feb 8.
4
The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity.炎症小体介导热激蛋白激活物酶-1 激活控制脂肪细胞分化和胰岛素敏感性。
Cell Metab. 2010 Dec 1;12(6):593-605. doi: 10.1016/j.cmet.2010.11.011.
5
The nuclear hormone receptor PPARγ as a therapeutic target in major diseases.核激素受体PPARγ作为主要疾病的治疗靶点。
ScientificWorldJournal. 2010 Nov 4;10:2181-97. doi: 10.1100/tsw.2010.213.
6
Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt.脂肪细胞中的 Fas 激活通过减少 Akt 来损害胰岛素刺激的葡萄糖摄取。
FEBS Lett. 2010 Oct 8;584(19):4187-92. doi: 10.1016/j.febslet.2010.08.052. Epub 2010 Sep 7.
7
TRAIL: a sword for killing tumors.TRAIL:肿瘤的“利剑”
Curr Med Chem. 2010;17(29):3309-17. doi: 10.2174/092986710793176285.
8
New insights into apoptosis signaling by Apo2L/TRAIL.Apo2L/TRAIL 诱导细胞凋亡信号的新见解。
Oncogene. 2010 Aug 26;29(34):4752-65. doi: 10.1038/onc.2010.221. Epub 2010 Jun 7.
9
Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer.一项在晚期癌症患者中进行的重组人 Apo2L/TRAIL(一种双重促凋亡受体激动剂)的 I 期剂量递增研究。
J Clin Oncol. 2010 Jun 10;28(17):2839-46. doi: 10.1200/JCO.2009.25.1991. Epub 2010 May 10.
10
Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis.鉴定白藜芦醇在脂肪细胞中促进细胞凋亡的新功能:SIRT1 非依赖性对 TRAIL 诱导凋亡的敏感性。
FASEB J. 2010 Jun;24(6):1997-2009. doi: 10.1096/fj.09-142943. Epub 2010 Jan 22.